RAAB SIMON 4

4 · FARO TECHNOLOGIES INC · Filed Sep 27, 2018

Form 4

Period: 2018-09-25

Director

Transactions

Exercise/Conversion
Employee Stock Option (right to buy)
2018-09-26−200→ 38,608 total
Exercise: $29.98Exp: 2022-12-04→ Common Stock (200 underlying)
Exercise/Conversion
Common Stock
2018-09-26$29.98/sh+200$5,996→ 30,247 total
Sale
Common Stock
2018-09-26$65.05/sh−200$13,010→ 30,047 total
Exercise/Conversion
Common Stock
2018-09-25$29.98/sh+980$29,380→ 31,027 total
Sale
Common Stock
2018-09-25$65.54/sh−980$64,234→ 30,047 total
Exercise/Conversion
Employee Stock Option (right to buy)
2018-09-25−980→ 38,808 total
Exercise: $29.98Exp: 2022-12-04→ Common Stock (980 underlying)

Holdings

Footnotes (5)

[F1]Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(1) adopted by Mr. Raab on August 13, 2018.
[F2]Represents the sale of 980 shares in multiple transactions ranging in price from $65.10 to $65.70 per share, resulting in a weighted average sale price of $65.5447. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
[F3]Represents shares held by Xenon Research, Inc., a corporation in which the reporting person has investment control over the shares of the issuer owned by such corporation. The reporting person and his wife, Diana Raab, own all of the outstanding shares of Xenon Research, Inc.
[F4]Represents shares held by a revocable trust of which the reporting person is settlor and trustee.
[F5]30,000 options vested on each of December 4, 2016 and December 4, 2017.

Documents

1 file